Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ·Healthcare·Biotechnology
$11.91
+1.45%
Mkt Cap $1.00B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$33.17
Range $27.00 – $42.00
Implied Upside
+178.5%
Consensus $33.17 vs current $11.91
NASDAQ·Healthcare·Biotechnology
$11.91
+1.45%
Mkt Cap $1.00B
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$33.17
Range $27.00 – $42.00
+178.5%
Consensus $33.17 vs current $11.91